(19)
(11) EP 0 648 218 A1

(12)

(43) Date of publication:
19.04.1995 Bulletin 1995/16

(21) Application number: 93914865.0

(22) Date of filing: 01.07.1993
(51) International Patent Classification (IPC): 
A61K 31/ 70( . )
A61K 31/ 7052( . )
A61P 31/ 12( . )
A61K 31/ 7042( . )
A61K 31/ 7076( . )
C07H 19/ 16( . )
(86) International application number:
PCT/GB1993/001388
(87) International publication number:
WO 1994/001443 (20.01.1994 Gazette 1994/03)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 02.07.1992 GB 19920014171
05.11.1992 GB 19920023180

(71) Applicant: THE WELLCOME FOUNDATION LIMITED
London NW1 2BP (GB)

(72) Inventors:
  • KOSZALKA, George, Walter
    Chapel Hill, NC 27514 (US)
  • VAN DRAANEN, Nanine Agneta
    Durham, NC 27713 (US)
  • FREEMAN, George, Andrew
    Raleigh, NC 27606 (US)
  • SHORT, Steven, Andersen
    Cary, NC 27511 (US)

(74) Representative: Garrett, Michael, et al 
The Wellcome Foundation Limited Group Patents and Agreements Langley Court
Beckenham Kent BR3 3BS
Beckenham Kent BR3 3BS (GB)

   


(54) THERAPEUTIC NUCLEOSIDES